1.
Chem Commun (Camb)
; 49(95): 11224-6, 2013 Dec 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24154537
RESUMO
Novel enantioselective catalysis involving a Pd(II)-Pd(IV) cycle was developed by utilizing a SPRIX ligand. Treatment of alkenyl alcohols with a catalytic amount of Pd-SPRIX and TfOH in the presence of PhI(OAc)2 gave optically active 3-oxy-tetrahydrofuran derivatives in good yields.